


33 Californie launches CaLySeed, new investment fund providing financial and strategic support to healthcare start-ups

Oncovita presents preclinical data on its promising MVdeltaC oncolytic vaccine at SITC Annual Meeting 2022

Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress

Positive results from AELIX’ HIV therapeutic vaccine clinical study published in Nature Medicine

ABL and Imugene partner to advance oncolytic virus candidate towards later phase clinical trials

L’écosystème de santé Belge montre une grande implication pour l’évènement européen HealthTech Innovation Days, les 13 à 14 octobre à Paris

admed laboratory adopts QuantaMatrix dRAST solution in routine clinical use

Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532
